Symptoms of respiratory syncytial virus, or RSV, may start off similar to a common cold, with sneezing and a runny nose. But ...
8hon MSN
Most positive tests for RSV so far this season in Canada have been among the youngest, federal data suggests. And while ...
Winter brings with it a higher risk of infectious diseases. Here are the common viral outbreaks seen in the United States and ...
Early results from 63 of the infants enrolled in the trial found the vaccine to be safe, tolerated and able to cut the chance ...
Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored ...
In a new study, the RSV drug nirsevimab was 93% effective at preventing young children from being hospitalized for the ...
The FDA flagged at least five cases of severe or very severe RSV lower respiratory tract infections in infants immunized with ...
The FDA has placed a hold on all clinical studies of vaccines for respiratory syncytial virus in infants due to safety concerns following a trial involving two mRNA-based vaccine candidates from ...
Cases of severe RSV in two Moderna vaccine candidates' trials raise questions about future
Ahead of an advisory committee meeting later this week, the FDA revealed that all studies for RSV vaccines in young children ...
Research led by the CDC and conducted at seven academic pediatric medical centers in the United States finds nirsevimab (sold ...
It's respiratory virus season, and statewide and local numbers show the gradual rise in cases. Here is what you can do.
Physicians in PA don’t expect to see the surges they saw during the first winters of the COVID-19 pandemic, but encouraged ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback